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Cancer cells are characterized by a high rate of glycolysis, even
under aerobic conditions, which is their primary energy source
(Eigenbrodt et al, 1985; Fiechter and Gmünder, 1989; Beckner
et al, 1990; Greiner et al, 1994). Glycolysis is controlled by
allosteric regulators, among which glucose 1,6-bisphosphate 
(Glc-1,6-P2) plays a major role in extrahepatic tissues (reviewed in
Beitner, 1979, 1984, 1985, 1990), as well as by reversible binding
of glycolytic enzymes to cytoskeleton (Arnold and Pette, 1968;
reviewed in Clarke et al, 1985; Beitner, 1993; Pagliaro, 1993;
Bereiter-Hahn et al, 1997). All glycolytic enzymes bind to
cytoskeleton except hexokinase (EC 2.7.1.1), which binds
reversibly to mitochondria, where it is linked to oxidative phos-
phorylation (Gots et al, 1972; Gots and Bessman, 1974; Viitanen
et al, 1984; Wilson, 1985; Kottke et al, 1988; Adams et al, 1991).
An increase in mitochondrially bound hexokinase was found in
tumour cells and it has been suggested that this binding plays an
important role in cancer cell metabolism (Arora and Pedersen,
1988; Fanciulli et al, 1994; reviewed in Golshani-Hebroni and
Bessman, 1997).
We have previously found that an increase in intracellular-free
calcium ion (Ca2+) in normal cells, induced by Ca2+-ionophore
A23187, or Ca2+-mobilizing hormones, exerts (through the
Ca2+–calmodulin complex), dual effects on cell energy metabolism
(reviewed in Beitner, 1993, 1998). While a physiological increase
in intracellular-free Ca2+ increases mitochondrial-bound hexo-
kinase and cytoskeleton-bound glycolytic enzymes, and thereby
stimulates adenosine 5´-triphosphate (ATP) production, a high
pathological rise in intracellular-free Ca2+ causes a reduction in all
the energy-producing systems in different cellular compartments,
leading to cell death (Beery et al, 1980; Lilling and Beitner, 1990;
Bassukevitz et al, 1992; Beitner and Lilling, 1993; Chen-Zion
et al, 1993). Our experiments have also revealed that calmodulin
antagonists are most effective drugs in the treatment of melanoma
(Glass-Marmor et al, 1996; Glass-Marmor and Beitner, 1997;
Beitner, 1998; Penso and Beitner, 1998).
In the present research we investigated how an increase in intra-
cellular-free Ca2+, induced by Ca2+-ionophore A23187, would
affect energy metabolism of melanoma cells. We studied its effect
on cytoskeletal phosphofructokinase (PFK) (EC 2.7.1.11), and
mitochondrially-bound hexokinase, the two key enzymes in
glycolysis, and the levels of Glc-1,6-P2, fructose 1,6-bisphosphate
(Fru-1,6-P2), ATP, and viability of the melanoma cells.
MATERIALS AND METHODS
Materials
Ca2+-ionophore A23187 was obtained from Sigma Chemical Co.
Other chemicals and enzymes were either from Sigma Chemical
Co. or from Boehringer Mannheim GmbH. Tissue culture reagents
were purchased from Biological Industries, Beit Haemek, Israel.
Cell culture
B16 F10 mouse melanoma cells were grown in RPMI-1640
medium supplemented with 10% fetal calf serum and antibiotics,
at 37°C in humidified atmosphere at 5% carbon dioxide and 95%
air. Cells were passaged two to three times weekly.
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Melanoma cells (8 ´ 105 cell ml–1) were seeded in tissue culture
plates (10 cm). After 48 h, cells were washed twice with phos-
phate-buffered saline (PBS). Then the cells were incubated at
37°C in PBS containing 5 mM glucose and 1.8 mM calcium
chloride in the absence and presence of Ca2+-ionophore A23187
for different concentrations. Ca2+-ionophore A23187 was dis-
solved in dimethyl sulphoxide (DMSO). DMSO was added to
the controls.
Extraction and determination of glucose
1,6-bisphosphate, fructose 1,6-bisphosphate and ATP
Glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP
were extracted from B16 melanoma cells, as described previously
(Glass-Marmor et al, 1996). Glucose 1,6-bisphosphate was
measured by the fluorometric method of Passonneau et al (1969);
fructose 1,6-bisphosphate and ATP were measured by the method
of Lowry et al (1964).
Separation and assay of bound and soluble enzymes
Separation of cytoskeleton-bound and soluble phosphofructo-
kinase from B16 melanoma cells was described previously (Glass-
Marmor and Beitner, 1997). Cytoskeleton-bound and soluble
phosphofructokinase were assayed as described previously
(Lilling and Beitner, 1990).
Separation and assay of mitochondrial-bound and soluble
hexokinase from B16 melanoma cells was described previously
(Penso and Beitner, 1998).
Measurement of intracellular free calcium
B16 melanoma cells were incubated with 4 mM Fura-2-AM for
40 min in balanced salt solution (BSS) (135 mM sodium chloride,
4.5 mM potassium chloride, 1.5 mM calcium chloride, 0.5 mM
magnesium chloride, 5.6 mM glucose, 10 mM HEPES, pH 7.4,
in double distilled water), at 37°C. Then the cells were harvested
using trypsin (0.25%)–EDTA (0.05%) and precipitated by centri-
fugate at 270 g for 10 min. The cell suspension (0.5 ´ 106 ml–1), in
BSS in 3-cm quartz cuvette, was excited at 335 nm with a slit 5-
nm wide, and emissions collected at 500 nm at 30°C (Hill
et al, 1989). Changes in fluorescence were recorded using a
Perkin-Elmer LS-50 fluorescent spectrophotometer equipped with
temperature-controlled stirred cuvette. To calibrate the fluores-
cence signal, we used 10 mM digitonin and 50 mM EGTA. Each
sample was treated with 10 mM Ca2+-ionophore A23187.
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Figure 1 Effect of Ca2+-ionophore A23187 (10 mM) on intracellular free
calcium, using Fura 2, in B16 melanoma cells. The resting level of
intracellular free calcium was 240 ± 24 nM (n = 4). The results shown are a
single representative experiment from six separate experiments
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Figure 2 Dose–response curves of the effect of Ca2+-ionophore A23187 on
glucose 1,6-bisphosphate (Glc-1,6-P2) (A) and fructose 1,6-bisphosphate
(Fru-1,6-P2) (B) levels in B16 melanoma cells. Cells were incubated for 1 h in
the absence and presence of different concentrations of Ca2+-ionophore
A23187. One hundred per cent Glc-1,6-P2 and Fru-1,6-P2 refers to
1.65 ± 0.09 and 14.5 ± 0.3 (nmol mg–1 protein) respectively. Each point is the
mean ± s.e.m. of 2–3 separate experiments which were performed in
triplicate. *P < 0.005Cell viability determination
After incubation in absence and presence of Ca2+-ionophore
A23187, the cells were harvested with trypsin (0.25%)–EDTA
(0.05%) and centrifuged for 10 min at 270 g. The precipitated cells
were suspended in PBS and counted in a haemocytometer
(Neubauer). Cell viability was determined by trypan blue dye
exclusion.
Protein measurement
Protein was measured by the method of Bradford (1976) with
crystalline bovine serum albumin as a standard.
RESULTS
The results presented in Figure 1 show that Ca2+-ionophore
A23187 induced an increase in intracellular concentration of free
Ca2+ and cell energy in melanoma 221
British Journal of Cancer (1999) 81(2), 219–224 © 1999 Cancer Research Campaign
02468 1 0
Ca
2+-ionophore A23187 (mM)
100
80
60
40
20
B
o
u
n
d
 
P
F
K
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
Soluble
Bound
420
380
340
300
260
220
180
140
100
S
o
l
u
b
l
e
 
P
F
K
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
Figure 3 Dose–response curves of the effect of Ca2+-ionophore A23187 on
cytoskeleton-bound and soluble phosphofructokinase (PFK) in B16
melanoma cells. Cells were incubated for 1 h in the absence and presence of
different concentrations of Ca2+-ionophore A23187. One hundred per cent
activity of bound and soluble phosphofructokinase was 70 ± 5 and 14 ± 1
(mU mg–1 protein) respectively. Each point is the mean ± s.e.m. of 2–3
separate experiments which were performed in triplicate. *P < 0.005
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Figure 4 Effect of Ca2+-inophore A23187 on cell viability in B16 melanoma
cells. Cells were incubated in the absence and presence of different
concentrations of Ca2+-ionophore A23187. One hundred per cent cell viability
refers to 5 ´ 106 cells ml–1. Values are the means ± s.e.m. of 2–3 separate
experiments which were performed in triplicate. *P < 0.005
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Figure 5 Effect of Ca2+-ionophore A23187 on cell viability and its relation to
the levels of glucose 1,6-bisphosphate (Glc-1,6-P2) and fructose 1,6-
bisphosphate (Fru-1,6-P2) and the binding of phosphofructokinase (PFK) to
cytoskeleton in B16 melanoma cells. Cells were incubated with and without
2.5 mM and 10 mM Ca2+-ionophore A23187 for 1 h. One hundred per cent cell
viability refers to 5 ´ 106 cells ml–1. One hundred per cent Glc-1,6-P2 and
Fru-1,6-P2 levels refer to 1.65 ± 0.09 and 14.5 ± 0.3. One hundred per cent
activity of bound PFK refers to 70 ± 5 (mU mg–1 protein). Values are the
mean ± s.e.m. of 2–3 separate experiments which were performed in
triplicate. *P < 0.005
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Figure 6 Dose–response curves of the effect of Ca2+-ionophore A23187 on
ATP levels in B16 melanoma cells. Cells were incubated for 1 h in the
absence and presence of different concentrations of Ca2+-ionophore A23187.
One hundred per cent ATP refers to 43.5 ± 2.1 (nmol mg–1 protein). Each
point is the mean ± s.e.m. of 2–3 separate experiments which were
performed in triplicate. *P < 0.05, **P < 0.005Ca2+ in B16 melanoma cells. Figure 2 shows that Ca2+-ionophore
A23187 exerted a concentration-dependent decrease in the levels
of Glc-1,6-P2 (Figure 2A) and Fru-1,6-P2 (Figure 2B) in melanoma
cells.
The results presented in Figure 3 show that Ca2+-ionophore
A23187 exerted a dose-dependent decrease in cytoskeleton-bound
phosphofructokinase in B16 melanoma cells, with a corresponding
increase in soluble activity. Phosphofructokinase activity was
assayed under maximal (optimal) conditions (pH 8.2), in which
the enzyme is not sensitive to allosteric effectors (Beitner et al,
1978). Therefore, changes in the levels of allosteric regulators
would not be expressed in its activity, and the results reveal solubi-
lization of the cytoskeleton-bound enzyme.
The results presented in Figure 4 show that Ca2+-ionophore
A23187 induced a concentration-dependent reduction in viable
melanoma cells. As shown in Figure 5, the decrease in Glc-1,6-P2,
Fru-1,6-P2 and cytoskeleton-bound phosphofructokinase, occurred
at lower concentrations of the drug than those required to decrease
cell viability.
As shown in Figure 6, the level of ATP was elevated by low
concentrations of Ca2+-ionophore A23187, reaching maximum at
5 mM, and thereafter it was markedly reduced. The elevation in
ATP resulted, most probably, from the concomitant increase in the
activity of mitochondrial-bound hexokinase (Figure 7), which is
linked to oxidative phosphorylation. A parallel increase in soluble
hexokinase was also found (Figure 7). Hexokinase activity was
assayed in these experiments under regulatory (suboptimal) condi-
tions, in which it is sensitive to allosteric inhibition by Glc-1,6-P2
(Beitner et al, 1979). As shown in Figure 8, the mitochondrial-
bound and soluble hexokinase from B16 melanoma cells exhibited
similar sensitivity to inhibition by Glc-1,6-P2. When hexokinase
activity was assayed under maximal (optimal) conditions, in
which it is not sensitive to inhibition by Glc-1,6-P2 (Beitner et al,
1979), no significant changes occurred in the activity of hexo-
kinase from both the mitochondrial and soluble fractions of
the cell; hexokinase maximal activity in the mitochondrial and
soluble fractions of controls was 125.4 ± 1.8 and 472.4 ± 13.6
(U mg–1 protein), respectively, and after treatment with 5 mM
Ca2+-ionophore A23187, it was 147.2 ± 4.4 and 466.8 ± 9.1
respectively.
DISCUSSION
Ca2+-ionophore A23187 induced an increase in intracellular-free
Ca2+ concentration in B16 melanoma cells (Figure 1). These
results are compatible with the results of Hill et al (1989). The
increase in intracellular-free Ca2+ in melanoma cells induced by
Ca2+-ionophore A23187 caused solubilization of cytoskeleton-
bound phosphofructokinase (Figure 3). The detachment of phos-
phofructokinase from cytoskeleton, would reduce cytoskeletal
glycolysis and, thereby, the provision of local ATP, in the vicinity
of the cytoskeleton membrane, and would affect cytoskeleton
structure (Clarke et al, 1985).
The present results also reveal that Ca2+-ionophore A23187
decreased the levels of Glc-1,6-P2 (Figure 2A) and Fru-1,6-P2
(Figure 2B), the two stimulatory signal molecules of glycolysis,
which would also lead to a reduction of cytosolic glycolysis and
ATP levels (Beitner, 1993). However, as shown in Figure 6, the
levels of ATP were not reduced by low concentrations of Ca2+-
ionophore A23187, but rather elevated, reaching a maximum
increase at a concentration of 5 mM, and thereafter decreased. The
source of the increased ATP at low concentrations of the
ionophore, is either mitochondrial or due to glycolysis.
Mitochondrial-bound hexokinase was activated at low
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Figure 7 Dose–response curves of the effect of Ca2+-ionophore A23187 on
mitochondrial-bound and soluble hexokinase in B16 melanoma cells. Cells
were incubated for 1 h in absence and presence of different concentrations of
Ca2+-ionophore A23187. One hundred per cent activity of bound and soluble
hexokinase was 8.97 ± 0.24 and 17.96 ± 0.41 (U mg–1 protein) respectively.
Each point is the mean ± s.e.m. of 2–3 separate experiments which were
performed in triplicate. *P < 0.005
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Figure 8 The inhibitory effect of Glc-1,6-P2 on the activity of mitochondrial-
bound and soluble hexokinase in B16 melanoma cells. One hundred per cent
activity of bound and soluble hexokinase was 3.44 ± 0.08 and 15.46 ± 0.32
(U mg–1 protein) respectively. Each point is the mean ± s.e.m. of 4 separate
experiments. P < 0.005 (each point vs control)concentrations of the ionophore (Figure 7), which correlated with
the increase in ATP (Figure 6), reaching a maximum at a concentra-
tion of 5 µM, and thereafter declined. Hexokinase was shown to bind
to porin at the contact sites between the mitochondrial inner and
outer membranes (Kottke et al, 1988; Adams et al, 1991; Brdiczka,
1991). The mitochondrially bound hexokinase preferentially utilizes
mitochondrially-generated ATP (Gots et al, 1972; Gots and
Bessman, 1974; Viitanen et al, 1984). In addition, the contacts were
shown to have a higher Ca2+-binding capacity compared to the outer
and inner mitochondrial membrane. The mitochondrial-bound
hexokinase enhances the uptake of Ca2+ by the mitochondria (Kottke
et al, 1988), and a rise in mitochondrial Ca2+ stimulates intramito-
chondrial oxidative metabolism and ATP production (Denton and
McCormack, 1990; McCormack and Denton, 1990).
The increase in mitochondrial-bound hexokinase was most
probably not a result of translocation from the cytosol, as activity
of the cytosolic (soluble) enzyme was also increased (Figure 7).
The activation of both the mitochondrial-bound and soluble
hexokinase resulted most probably from the decrease in Glc-1,6-P2
levels (Figure 2A), which is a potent inhibitor of hexokinase from
both the mitochondrial and soluble fractions of the melanoma cells
(Figure 8). The findings that the activity of hexokinase was not
changed under maximal (optimal) conditions, in which the enzyme
is not subject to inhibition by Glc-1,6-P2, strengthens this postula-
tion. The increase in ATP induced by low concentrations of Ca2+-
ionophore, which most probably results from the increase in the
mitochondrial-bound hexokinase activity, reflects a defence mech-
anism to prevent cell death. This mechanism can no longer operate
at high concentrations of the Ca2+-ionophore, which causes a
decrease in mitochondrial-bound hexokinase (Figure 7), leading to
a fall in ATP (Figure 6) and cell death (Figure 4). These experi-
ments fit with the general schemes of apoptosis following accumu-
lation of intracellular free calcium, as described recently by Ichas
and Mazat (1998). The increase in cytosolic calcium can induce an
increase in mitochondrial calcium, leading to an opening of the
permeability transition pore, accompanied by a drop in mitochon-
drial transmembrane potential.
In contrast to hexokinase, the activity of cytoskeleton-bound
phosphofructokinase was not increased by low concentrations of
Ca2+-ionophore but rather markedly reduced (Figure 3). This
differs from normal tissues, in which we found a dual effect of
Ca2+ on cytoskeleton-bound glycolytic enzymes (Beitner, 1993,
1998). This may be due to the changes in cytoskeleton structure
and function in cancer cells (Rao and Cohen, 1991).
The Ca2+-induced decrease in the levels of Glc-1,6-P2 and
Fru-1,6-P2 and the detachment of phosphofructokinase from
cytoskeleton, occurred at lower concentrations of the drug than the
reduction in cell viability (Figure 5), which indicates that these are
primary changes which lead to cell death.
In summary, the present results reveal that accumulation of
high concentrations of intracellular free Ca2+ in melanoma cells,
induces a reduction in the energy-producing systems in different
cellular compartments, leading to melanoma cell death. This may
be the mechanism of action of certain drugs which are already
used for melanoma treatment, and may also serve to evaluate the
therapeutic action of new drugs.
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